Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 101, Issue 4, Pages 305-314Publisher
WILEY-LISS
DOI: 10.1002/jso.21483
Keywords
gastric cancer; neoadjuvant therapy; chemotherapy; gastrectomy; cytology
Ask authors/readers for more resources
Treatment of gastric cancer has evolved with the advent of randomized trials demonstrating chemotherapeutic agents with efficacy in advanced disease. Level I evidence Supports delivering chemotherapy in the neoadjuvant settings the data shows improvement in progression-free and overall survival. A clinical response to therapy is associated with improved R0 resection rates, pathologic response. and outcome in patients with locally advanced disease. Early assessment of metabolic response to therapy can potentially be utilized to tailor treatment. J. Surg. Oncol. 2010; 101:305-314. (C) 2010 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available